Your Health, We Care
Release date: 2024-07-10 15:07:56 Recommended: 134
Selpercatinib LOXO-292 is a RET kinase inhibitor used to treat three types of cancer: adult metastatic RET fusion positive non-small cell lung cancer (NSCLC) patients; Adult and pediatric advanced or metastatic RET mutation positive medullary thyroid cancer (MTC) patients aged 12 and above who require systematic treatment; Adult and pediatric advanced or metastatic RET fusion positive thyroid cancer patients aged 12 and above who are refractory to radioactive iodine and require systematic treatment.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：208Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：221Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：193Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：159Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：291Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：171Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：326Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：197Release date: 2024-07-09
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) ···【more】
Recommended：155Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the man···【more】
Recommended：152Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Fo···【more】
Recommended：168Release date: 2024-12-30
The new indication involves the treatment of adult patients with locally advance···【more】
Recommended：158Release date: 2024-12-24
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont···【more】
Recommended：144Release date: 2024-12-17
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-C···【more】
Recommended：104Release date: 2024-12-13
